Sponsor Layout Testing
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce vel consectetur diam. In vel metus nec erat mollis luctus. Fusce elementum in tellus ac accumsan. Donec ultricies massa at libero cursus, quis gravida leo gravida. Vivamus turpis arcu, fermentum pellentesque velit at, consectetur rhoncus elit. Proin vehicula id ipsum ac fermentum. Aliquam sollicitudin gravida sapien, quis finibus tellus gravida at. Nam ut quam dolor. Cras consequat dapibus ornare.
Sed vitae accumsan leo, a finibus arcu. Curabitur fringilla scelerisque purus, porttitor sodales ipsum imperdiet quis. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae; Ut pretium et leo in accumsan. Curabitur vitae luctus libero, vel dapibus sem. Fusce tincidunt nunc massa, id convallis metus lobortis in. Phasellus sed auctor tortor. Mauris faucibus, mauris et fringilla pharetra, ex sem efficitur odio, ac condimentum leo ante sed leo.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
We’re a medicine company turning science into healing to make life better for people around the world.
Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world’s most significant health challenges. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: “Take what you find here and make it better and better.”
But we’re not only dedicated to making medicines. We go beyond medicine to deliver innovative clinical trials that reflect the diversity of our world and work to ensure our medicines are accessible and affordable. Learn more at www.lilly.com/who-we-are/about-lilly.
Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced technology and always-on support when and how it is needed. Medtronic has pioneered first-of-its-kind innovations for over 40 years and is committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront. Today we offer the MiniMed™ 780G insulin pump system, the InPen™ smart insulin pen and the i-Port Advance™ injection port, and we continue to innovate further. With a renewed focus on creating products that are easy to use, we hope our future technologies will enable people to focus more on life, and not diabetes. To learn more, visit www.medtronicdiabetes.com and follow us on Facebook, Instagram, TikTok, YouTube and LinkedIn.
Tandem Diabetes Care creates new possibilities for people living with diabetes, their loved ones, and their healthcare providers through a positively different experience. We deliver innovative products and automated insulin delivery systems — including Tandem Mobi and the t:slim X2 — to people who require insulin therapy. For more information, visit tandemdiabetes.com.
